Critical illness neuromuscular abnormalities (Q34761337)

4 August 2017

1 reference

title

Critical illness neuromuscular abnormalities (English)

1 reference

4 August 2017

Scott Lorin

1

1 reference

4 August 2017

David M Nierman

series ordinal

2

1 reference

4 August 2017

publication date

1 July 2002

1 reference

4 August 2017

published in

Critical Care Clinics

1 reference

4 August 2017

volume

18

1 reference

4 August 2017

issue

3

1 reference

4 August 2017

page(s)

553-568

1 reference

Neuromuscular causes of prolonged ventilator dependency

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Neurologic complications of critical medical illnesses.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Prevalence and severity of neurologic dysfunction in critically ill patients. Influence on need for continued mechanical ventilation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Patterns of neurophysiological abnormality in prolonged critical illness

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Causes of neuromuscular weakness in the intensive care unit: a study of ninety-two patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Critical illness myopathy and neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Neuromuscular disorders associated with failure to wean from the ventilator

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Acquired neuromuscular disorders in critically ill patients: a systematic review. Groupe de Reflexion et d'Etude sur les Neuromyopathies En Reanimation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Incidence and onset of critical illness polyneuropathy in patients with septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Critical illness polyneuropathy. A review of the literature, definition and pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Critical illness polyneuropathy. A complication of sepsis and multiple organ failure

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Sepsis and catecholamine support are the major risk factors for critical illness polyneuropathy after open heart surgery'.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Tumor necrosis factor and interleukin-6 in critical illness polyneuromyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Critical illness polyneuropathy and myopathy (CIPNM): evidence for local immune activation by cytokine-expression in the muscle tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Critical illness polyneuropathy: clinical findings and cell culture assay of neurotoxicity assessed by a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Intensive insulin therapy in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Polyneuropathies in critically ill patients: a prospective evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Risk factors for the development of polyneuropathy and myopathy in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Predominant involvement of motor fibres in patients with critical illness polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Critical illness polyneuropathy in multiple organ dysfunction syndrome and weaning from the ventilator

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Round table conference on ventilatory failure, Brussels, Belgium, March 16-18, 1991

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Peripheral nerve function in sepsis and multiple organ failure

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Motor neuropathy in a patient with Legionnaires' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Peripheral neuropathy—an unusual complication of meningococcemia

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Response of man to endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Polyradiculoneuritis and Mycoplasma pneumoniae infection

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Critical illness polyneuropathy: a summary of the literature on rehabilitation outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Critical illness polyneuromyopathy after artificial respiration

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Critical illness polyneuropathy: a new iatrogenically induced syndrome after cardiac surgery?

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Left lower lobe atelectasis and consolidation following cardiac surgery: the effect of topical cooling on the phrenic nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Elevated hemidiaphragm after cardiac operations: incidence, prognosis, and relationship to the use of topical ice slush

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Incidence and aetiology of a raised hemidiaphragm after cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Effects of temperature on phrenic nerve and diaphragmatic function during cardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Phrenic nerve function and its relationship to atelectasis after coronary artery bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Phrenic nerve injury. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Diabetes mellitus, internal thoracic artery grafting, and risk of an elevated hemidiaphragm after coronary artery bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Technology under Medicare diagnosis-related groups prospective payment. Implications for medical intensive care

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Incidence and natural history of phrenic neuropathy occurring during open heart surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Phrenic nerve injury in infants and children undergoing cardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Phrenic nerve injury after coronary artery bypass grafting: will it go away?

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Delay of extubation in neonates and children after cardiac surgery: impact of ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Recovery after unilateral phrenic injury associated with coronary artery revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Myopathy in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Acute type II myofiber atrophy in critical illness

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Acute myopathy after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Acute myopathy and neuropathy in status asthmaticus: case report and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Acute quadriplegic myopathy: a complication of treatment with steroids, nondepolarizing blocking agents, or both

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Severe myopathy after status asthmaticus

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Necrotizing myopathy in critically-ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Myopathy in severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Neuromuscular complications in patients given Pavulon (pancuronium bromide) during artificial ventilation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Vecuronium-associated axonal motor neuropathy: a variant of critical illness polyneuropathy?

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Prolonged weakness after long-term infusion of vecuronium bromide

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Prolonged neuromuscular blockade with atracurium.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Prolonged paralysis after treatment with neuromuscular junction blocking agents

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Muscle strength following anaesthesia with atracurium and pancuronium.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Persistent paralysis in critically ill patients after long-term administration of vecuronium

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Does vecuronium accumulate in the renal transplant patient?

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Clinical and electrophysiological findings in critical illness polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

A NERVE GROWTH-STIMULATING FACTOR ISOLATED FROM SARCOM AS 37 AND 180.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Nerve growth factor signaling, neuroprotection, and neural repair

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Peripheral neuropathies and neurotrophic factors: animal models and clinical perspectives.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Neurotrophin‐3 reverses experimental cisplatin‐induced peripheral sensory neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

The use of insulin-like growth factor I in the prevention of vincristine neuropathy in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Nerve growth factor prevents experimental cisplatin neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Nerve growth factor prevents toxic neuropathy in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Treatment of diabetic polyneuropathy with the neurotrophic peptide ORG 2766

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Nerve growth factor in neurological and non-neurological diseases: basic findings and emerging pharmacological prospectives.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

Critical illness polyneuropathy: clinical findings and outcomes of a frequent cause of neuromuscular weaning failure

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2802%2900003-9

7 January 2021

10.1016/S0749-0704(02)00003-9

Identifiers

DOI

1 reference

4 August 2017

1 reference